STAT5 phosphorylation was next compared in peripheral blood CD4+ T cells from the patient (visit S3) and from pediatric IBD patients with active intestinal inflammation (“PIBD inflammation”) or in clinical remission (“PIBD remission”). Here, CD4 is linked to inflammatory bowel disease.